Published in Am J Epidemiol on September 29, 2007
Multitargeted therapy of cancer by green tea polyphenols. Cancer Lett (2008) 2.13
The relationship between nutrition and prostate cancer: is more always better? Eur Urol (2012) 1.66
Plasma organochlorines and subsequent risk of prostate cancer in Japanese men: a nested case-control study. Environ Health Perspect (2010) 1.54
Green tea polyphenols for prostate cancer chemoprevention: a translational perspective. Phytomedicine (2010) 1.37
Tea and cancer prevention: epidemiological studies. Pharmacol Res (2011) 1.27
The biological kinship of hypoxia with CSC and EMT and their relationship with deregulated expression of miRNAs and tumor aggressiveness. Biochim Biophys Acta (2012) 1.26
Promoter demethylation and chromatin remodeling by green tea polyphenols leads to re-expression of GSTP1 in human prostate cancer cells. Int J Cancer (2010) 1.22
Review: green tea polyphenols in chemoprevention of prostate cancer: preclinical and clinical studies. Nutr Cancer (2009) 1.22
Prostate cancer in East Asia: evolving trend over the last decade. Asian J Androl (2015) 1.22
Green tea polyphenols and metabolites in prostatectomy tissue: implications for cancer prevention. Cancer Prev Res (Phila) (2010) 1.12
Antioxidative and anti-carcinogenic activities of tea polyphenols. Arch Toxicol (2008) 1.11
Tea and health: studies in humans. Curr Pharm Des (2013) 1.10
Polyphenols: key issues involved in chemoprevention of prostate cancer. Oxid Med Cell Longev (2012) 1.08
Chemopreventive effects of tea in prostate cancer: green tea versus black tea. Mol Nutr Food Res (2011) 1.06
EGCG, green tea polyphenols and their synthetic analogs and prodrugs for human cancer prevention and treatment. Adv Clin Chem (2011) 1.05
Cancer prevention by green tea: evidence from epidemiologic studies. Am J Clin Nutr (2013) 1.01
The role of nutraceuticals in the regulation of Wnt and Hedgehog signaling in cancer. Cancer Metastasis Rev (2010) 1.00
Nutraceuticals and prostate cancer prevention: a current review. Nat Rev Urol (2009) 1.00
Recent advances on tea polyphenols. Front Biosci (Elite Ed) (2012) 1.00
Nutrition, dietary interventions and prostate cancer: the latest evidence. BMC Med (2015) 0.98
Green tea polyphenols as proteasome inhibitors: implication in chemoprevention. Curr Cancer Drug Targets (2011) 0.98
Mismatch repair gene MSH3 polymorphism is associated with the risk of sporadic prostate cancer. J Urol (2008) 0.97
Green and black tea intake in relation to prostate cancer risk among Singapore Chinese. Cancer Causes Control (2012) 0.94
Going Green: The Role of the Green Tea Component EGCG in Chemoprevention. J Carcinog Mutagen (2013) 0.93
Epigallocatechin Gallate Nanodelivery Systems for Cancer Therapy. Nutrients (2016) 0.93
Nitric oxide as a target of complementary and alternative medicines to prevent and treat inflammation and cancer. Cancer Lett (2008) 0.92
Tea and human health: biomedical functions of tea active components and current issues. J Zhejiang Univ Sci B (2015) 0.91
Lack of evidence for green tea polyphenols as DNA methylation inhibitors in murine prostate. Cancer Prev Res (Phila) (2009) 0.90
Butanol fraction containing berberine or related compound from nexrutine inhibits NFkappaB signaling and induces apoptosis in prostate cancer cells. Prostate (2009) 0.90
Dietary antioxidants and prostate cancer: a review. Nutr Cancer (2013) 0.89
Modulation of signaling pathways in prostate cancer by green tea polyphenols. Biochem Pharmacol (2012) 0.89
Tea consumption and prostate cancer: an updated meta-analysis. World J Surg Oncol (2014) 0.88
Green tea (Camellia sinensis) and cancer prevention: a systematic review of randomized trials and epidemiological studies. Chin Med (2008) 0.88
Protection against oxidative DNA damage and stress in human prostate by glutathione S-transferase P1. Mol Carcinog (2012) 0.87
The strategies to control prostate cancer by chemoprevention approaches. Mutat Res (2014) 0.87
Significance of common variants on human chromosome 8q24 in relation to the risk of prostate cancer in native Japanese men. BMC Genet (2009) 0.87
Green tea drinking and subsequent risk of breast cancer in a population-based cohort of Japanese women. Breast Cancer Res (2010) 0.86
Autophagy inhibition contributes to the synergistic interaction between EGCG and doxorubicin to kill the hepatoma Hep3B cells. PLoS One (2014) 0.86
Polyphenon E inhibits the growth of human Barrett's and aerodigestive adenocarcinoma cells by suppressing cyclin D1 expression. Clin Cancer Res (2009) 0.85
Tea and health: preventive and therapeutic usefulness in the elderly? Curr Opin Clin Nutr Metab Care (2009) 0.85
Anticancer activity of green tea polyphenols in prostate gland. Oxid Med Cell Longev (2012) 0.84
Tea consumption and the risk of five major cancers: a dose-response meta-analysis of prospective studies. BMC Cancer (2014) 0.84
Implications of Green Tea and Its Constituents in the Prevention of Cancer via the Modulation of Cell Signalling Pathway. Biomed Res Int (2015) 0.84
Kallikrein 3 and vitamin D receptor polymorphisms: potentials environmental risk factors for prostate cancer. Diagn Pathol (2014) 0.83
Green tea catechin, epigallocatechin-3-gallate, attenuates the cell viability of human non-small-cell lung cancer A549 cells via reducing Bcl-xL expression. Exp Ther Med (2014) 0.83
Targeting CSC-related miRNAs for cancer therapy by natural agents. Curr Drug Targets (2012) 0.83
Dietary factors and risk for advanced prostate cancer. Eur J Cancer Prev (2014) 0.83
Elucidating polypharmacological mechanisms of polyphenols by gene module profile analysis. Int J Mol Sci (2014) 0.81
Chemoprevention in gastrointestinal physiology and disease. Natural products and microbiome. Am J Physiol Gastrointest Liver Physiol (2014) 0.80
Novel targets for prostate cancer chemoprevention. Endocr Relat Cancer (2010) 0.80
Recent progress on nutraceutical research in prostate cancer. Cancer Metastasis Rev (2014) 0.80
The green tea catechin epigallocatechin gallate (EGCG) blocks cell motility, chemotaxis and development in Dictyostelium discoideum. PLoS One (2013) 0.79
The association of tea consumption and the risk and progression of prostate cancer: a meta-analysis. Int J Clin Exp Med (2014) 0.78
Nanoencapsulation of natural triterpenoid celastrol for prostate cancer treatment. Int J Nanomedicine (2015) 0.77
Extracting the Benefit of Nexrutine(®) for Cancer Prevention. Curr Pharmacol Rep (2015) 0.77
A pilot study to investigate if New Zealand men with prostate cancer benefit from a Mediterranean-style diet. PeerJ (2015) 0.77
Analysis of the effect of the active compound of green tea (EGCG) on the proliferation of peripheral blood mononuclear cells. BMC Complement Altern Med (2014) 0.76
Prevention strategies in prostate cancer. Curr Oncol (2010) 0.76
Risk and preventive factors for prostate cancer in Japan: The Japan Public Health Center-based prospective (JPHC) study. J Epidemiol (2016) 0.75
Epigallocatechin-3-gallate regulates the expression of Kruppel-like factor 4 through myocyte enhancer factor 2A. Cell Stress Chaperones (2013) 0.75
Targeted nanoparticles encapsulating (-)-epigallocatechin-3-gallate for prostate cancer prevention and therapy. Sci Rep (2017) 0.75
Plasma 25-hydroxy vitamin D and subsequent prostate cancer risk in a nested Case-Control study in Japan: The JPHC study. Eur J Clin Nutr (2016) 0.75
Re: "Green tea consumption and prostate cancer risk in Japanese men: a prospective study". Am J Epidemiol (2008) 0.75
Diet, Lifestyles, Family History, and Prostate Cancer Incidence in an East Algerian Patient Group. Biomed Res Int (2016) 0.75
Protective Effect of Green Tea (Camellia sinensis (L.) Kuntze) against Prostate Cancer: From In Vitro Data to Algerian Patients. Evid Based Complement Alternat Med (2017) 0.75
Green tea and the risk of prostate cancer: A systematic review and meta-analysis. Medicine (Baltimore) (2017) 0.75
Cholesterol Metabolism and Prostate Cancer Lethality. Cancer Res (2016) 0.75
Epigallocatechin gallate inhibits the growth of MDA-MB-231 breast cancer cells via inactivation of the β-catenin signaling pathway. Oncol Lett (2017) 0.75
Green Tea Catechins for Prostate Cancer Prevention: Present Achievements and Future Challenges. Antioxidants (Basel) (2017) 0.75
Epigallocatechin-3-gallate inhibits H2O2-induced apoptosis in Mouse Vascular Smooth Muscle Cells via 67kD Laminin Receptor. Sci Rep (2017) 0.75
What has made the population of Japan healthy? Lancet (2011) 8.18
Association between body-mass index and risk of death in more than 1 million Asians. N Engl J Med (2011) 6.89
Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med (2006) 2.84
Epidemiology of esophageal cancer in Japan and China. J Epidemiol (2013) 2.66
Hepatitis B and C virus infection and hepatocellular carcinoma in China: a review of epidemiology and control measures. J Epidemiol (2011) 2.37
The impact of green tea and coffee consumption on the reduced risk of stroke incidence in Japanese population: the Japan public health center-based study cohort. Stroke (2013) 2.27
Diet and the risk of gastric cancer: review of epidemiological evidence. Gastric Cancer (2007) 2.25
Soy, isoflavones, and breast cancer risk in Japan. J Natl Cancer Inst (2003) 2.18
Intake of fish and n3 fatty acids and risk of coronary heart disease among Japanese: the Japan Public Health Center-Based (JPHC) Study Cohort I. Circulation (2006) 2.12
Surgical complications of posterior lumbar interbody fusion with total facetectomy in 251 patients. J Neurosurg Spine (2006) 2.11
Socioeconomic status inconsistency and risk of stroke among Japanese middle-aged women. Stroke (2014) 2.00
Consumption of n-3 fatty acids and fish reduces risk of hepatocellular carcinoma. Gastroenterology (2012) 2.00
Identification of a functional genetic variant at 16q12.1 for breast cancer risk: results from the Asia Breast Cancer Consortium. PLoS Genet (2010) 1.98
Fruit and vegetable intake and risk of breast cancer by hormone receptor status. J Natl Cancer Inst (2013) 1.94
Genome-wide association study in east Asians identifies novel susceptibility loci for breast cancer. PLoS Genet (2012) 1.91
Comparative epidemiology of gastric cancer between Japan and China. World J Gastroenterol (2011) 1.89
Consumption of sodium and salted foods in relation to cancer and cardiovascular disease: the Japan Public Health Center-based Prospective Study. Am J Clin Nutr (2009) 1.87
Associations of body mass index, smoking, and alcohol consumption with prostate cancer mortality in the Asia Cohort Consortium. Am J Epidemiol (2015) 1.87
Demographics, lifestyles, health characteristics, and dietary intake among dietary supplement users in Japan. Int J Epidemiol (2003) 1.85
Soy product and isoflavone consumption in relation to prostate cancer in Japanese men. Cancer Epidemiol Biomarkers Prev (2007) 1.85
Population attributable fraction of mortality associated with tobacco smoking in Japan: a pooled analysis of three large-scale cohort studies. J Epidemiol (2008) 1.72
Adult mortality attributable to preventable risk factors for non-communicable diseases and injuries in Japan: a comparative risk assessment. PLoS Med (2012) 1.70
Type A behaviour and risk of coronary heart disease: the JPHC Study. Int J Epidemiol (2008) 1.68
Histopathological criteria for additional treatment after endoscopic mucosal resection for esophageal cancer: analysis of 464 surgically resected cases. Mod Pathol (2006) 1.68
Risk factors for adjacent segment degeneration after PLIF. Spine (Phila Pa 1976) (2004) 1.65
Alcohol consumption and suicide among middle-aged men in Japan. Br J Psychiatry (2006) 1.62
Rice intake and type 2 diabetes in Japanese men and women: the Japan Public Health Center-based Prospective Study. Am J Clin Nutr (2010) 1.61
Meat intake and cause-specific mortality: a pooled analysis of Asian prospective cohort studies. Am J Clin Nutr (2013) 1.61
Decreased serum free testosterone in workers exposed to high levels of di-n-butyl phthalate (DBP) and di-2-ethylhexyl phthalate (DEHP): a cross-sectional study in China. Environ Health Perspect (2006) 1.60
Plasma folate and risk of colorectal cancer in a nested case-control study: the Japan Public Health Center-based prospective study. Cancer Causes Control (2007) 1.59
Replication and functional genomic analyses of the breast cancer susceptibility locus at 6q25.1 generalize its importance in women of chinese, Japanese, and European ancestry. Cancer Res (2011) 1.59
Daily total physical activity level and premature death in men and women: results from a large-scale population-based cohort study in Japan (JPHC study). Ann Epidemiol (2008) 1.58
Association between lung cancer incidence and family history of lung cancer: data from a large-scale population-based cohort study, the JPHC study. Chest (2006) 1.57
Development of a prediction model for 10-year risk of hepatocellular carcinoma in middle-aged Japanese: the Japan Public Health Center-based Prospective Study Cohort II. Prev Med (2012) 1.56
Genome-wide association study identifies breast cancer risk variant at 10q21.2: results from the Asia Breast Cancer Consortium. Hum Mol Genet (2011) 1.55
Dietary intake of saturated fatty acids and incident stroke and coronary heart disease in Japanese communities: the JPHC Study. Eur Heart J (2013) 1.55
Body mass index and diabetes in Asia: a cross-sectional pooled analysis of 900,000 individuals in the Asia cohort consortium. PLoS One (2011) 1.55
Plasma organochlorines and subsequent risk of prostate cancer in Japanese men: a nested case-control study. Environ Health Perspect (2010) 1.54
A population-based cohort study for the risk factors of HCC among hepatitis B virus mono-infected subjects in Japan. J Gastroenterol (2010) 1.53
Fragment c gamma receptor gene polymorphisms and breast cancer risk in case-control studies in Japanese, Japanese Brazilians, and non-Japanese Brazilians. Breast Cancer Res Treat (2010) 1.53
Reproductive factors, hormone use and the risk of lung cancer among middle-aged never-smoking Japanese women: a large-scale population-based cohort study. Int J Cancer (2005) 1.49
Diabetes and the risk of coronary heart disease in the general Japanese population: the Japan Public Health Center-based prospective (JPHC) study. Atherosclerosis (2011) 1.48
Alcohol consumption and other risk factors for self-reported diabetes among middle-aged Japanese: a population-based prospective study in the JPHC study cohort I. Diabet Med (2005) 1.46
Gene-environment Interactions and Polymorphism Studies of Cancer Risk in the Hospital-based Epidemiologic Research Program at Aichi Cancer Center II (HERPACC-II). Asian Pac J Cancer Prev (2001) 1.45
Plasma C-peptide, insulin-like growth factor-I, insulin-like growth factor binding proteins and risk of colorectal cancer in a nested case-control study: the Japan public health center-based prospective study. Int J Cancer (2007) 1.44